Vibativ (Theravance Biopharma R&D, Inc.)
Welcome to the PulseAid listing for the Vibativ drug offered from Theravance Biopharma R&D, Inc.. This Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Theravance Biopharma R&D, Inc. |
| NON-PROPRIETARY NAME: | telavancin hydrochloride |
| SUBSTANCE NAME: | TELAVANCIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-11-05 |
| END MARKETING DATE: | 0000-00-00 |
Vibativ HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vibativ from Theravance Biopharma R&D, Inc. |
| LABELER NAME: | Theravance Biopharma R&D, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/mL) |
| START MARKETING DATE: | 2009-11-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62847-001_3acb805d-4fe0-4f56-9c7d-a4c2bd9eb8aa |
| PRODUCT NDC: | 62847-001 |
| APPLICATION NUMBER: | NDA022110 |
Other TELAVANCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
